データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
88416-50-6O.O.O.O.O=P([O-])(O)C(Cl)(Cl)P(=O)([O-])O.[Na+].[Na+]XWHPUCFOTRBMGS-UHFFFAOYSA-L88416-50-6DTXSID40237035CHEMBL1520188CHEBI:59587安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
説明Bisphosphonates bind strongly to bone and reduce bone resorption through effects on both osteoclasts and osteoblasts. Clodronate is a non-nitrogenous bisphosphonate that has been used in the treatment of osteoporosis and other metabolic bone diseases. It binds to hydroxyapatite crystals with an affinity constant of 0.72 μM, inhibiting their growth (IC50 = 1.34 μM) and bone resorption. Clondronate is metabolized intracellularly to a β-γ-methylene analog of ATP that is cytotoxic to both osteoclasts and macrophages, which belong to the same cell lineage as osteoclasts. Liposome-encapsulated bisphosphonates such as clodronate have been used in biological research to selectively deplete macrophage-like cells and cancer cells.
使用Disodium Clodronate Tetrahydrate is a bisphosphonate bone growth regulator.
現在のフィルター条件では反応記録がありません。
読み込み中…
定義ChEBI: The tetrahydrate of the disodium salt of clodronic acid. It inhibits bone resorption and soft tissue calcification, and is used as an adjunct in the treatment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions nd bone pain associated with skeletal metastases.